|
Bayer HealthCare starts special lab space-model CoLaborator™ for promising life science companies
|
11 September 2012 |
|
Bayer reports strong business performance in the second quarter of 2012
|
31 July 2012 |
|
FDA grants priority review to the new drug application for Bayer's Regorafenib
|
28 June 2012 |
|
Bayer's Regorafenib submitted for EU and US marketing authorization
|
23 May 2012 |
|
Encouraging start to the year for Bayer
|
26 April 2012 |
|
Bayer HealthCare and Beijing's Tsinghua University extend innovative drug discovery partnership
|
28 March 2012 |
|
Bayer HealthCare to Share Lab Space with Start-Up Companies
|
09 January 2012 |
|
Four potential blockbusters in the Pharma pipeline
|
20 December 2011 |
|
Bayer plans further expansion in Asia
|
16 November 2011 |
|
After a good third quarter: Bayer confirms Group outlook
|
28 October 2011 |
|
Bayer HealthCare and Onyx Pharmaceuticals Restructure Global Oncology Partnership
|
17 October 2011 |
|
Bayer Confident in Results of ROCKET AF Study
|
07 September 2011 |
|
Bayer Healthcare to acquire Pathway Medical Technologies
|
01 September 2011 |
|
FDA Grants Fast Track Designation to Bayer's Investigational Compound Alpharadin™
|
23 August 2011 |
|
Bayer to support WHO and Stop Tuberculosis Partnership in fighting tuberculosis
|
15 August 2011 |
|
Results of ROCKET AF Study of Bayer’s Xarelto® (Rivaroxaban)
|
11 August 2011 |
|
Bayer continues positive momentum
|
01 August 2011 |
|
Bayer advances research in the area of pulmonary hypertension
|
01 July 2011 |
|
Major Subgroup Analysis Shows Bayer's Rivaroxaban is Highly Effective in the Prevention of Recurrent Strokes
|
26 May 2011 |
|
Bayer off to a successful start to 2011
|
02 May 2011 |